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Abstract
Background: The aims of the study were to assess the health preference and health-related quality of life (HRQOL) in
patients with colorectal neoplasms (CRN), and to determine the clinical correlates that significantly influence the HRQOL of
patients.
Methods: Five hundred and fifty-four CRN patients, inclusive of colorectal polyp or cancer, who attended the colorectal
specialist outpatient clinic at Queen Mary Hospital in Hong Kong between October 2009 and July 2010, were included.
Patients were interviewed with questionnaires on socio-demographic characteristics, and generic and health preference
measures of HRQOL using the SF-12 and SF-6D Health Surveys, respectively. Clinical information on stage of disease at
diagnosis, time since diagnosis, primary tumour site was extracted from electronic case record. Mean HRQOL and health
preference scores of CRN patients were compared with age-sex matched controls from the Chinese general population
using independent t-test. Multiple linear regression analyses were conducted to explore the associations of clinical
characteristics with HRQOL measures with the adjustment of socio-demographic characteristics.
Results: Cross-sectional data of 515 eligible patients responded to the whole questionnaires were included in outcome
analysis. In comparison with age-sex matched normative values, CRN patients reported comparable physical-related HRQOL
but better mental-related HRQOL. Amongst CRN patients, time since diagnosis was positively associated with health
preference score whilst patients with rectal neoplasms had lower health preference and physical-related HRQOL scores than
those with sigmoid neoplasms. Health preference and HRQOL scores were significantly lower in patients with stage IV
colorectal cancer than those with other less severe stages, indicating that progressive decline from low-risk polyp to stage IV
colorectal cancer was observed in HRQOL scores.
Conclusion: In CRN patients, a more advanced stage of disease was associated with worse HRQOL scores. Despite
potentially adverse effect of disease on physical-related HRQOL, the mental-related HRQOL of CRN patients were better than
that of Chinese general population.
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Introduction
Colorectal neoplasms (CRN) represent a wide spectrum of
disease transition from precancerous colorectal polyps to colorectal
cancer. In the past, disease management was principally evaluated
by the effectiveness in prolonging survival and reducing disease-
related complications and presentation of symptoms. The main-
tenance of health-related quality of life (HRQOL) following
screening and treatment has driven an important new direction in
research and clinical practice for patients with CRN. The
assessment of HRQOL on CRN has also increased the
understanding in the treatment efficiency and effectiveness, and
service needs of rehabilitation[1] for the interest of patients and
clinicians, and subsequently facilitated the clinical decision
makings[2].
There is no consensus on whether the HRQOL of CRN
patients was influenced by clinical factors. For instance, there have
been few attempts to characterize the associations of HRQOL
with the cancer stages and the time since cancer diagnosis [3–5].
Evidence from the US studies did not demonstrate any associa-
tions between HRQOL and time since diagnosis in colorectal
cancer patients[3–5]. Significant associations between HRQOL
and stage at cancer diagnosis did not exist in colorectal cancer
survivors[3,4] but did happen in mixture of survivors and non-
survivors[5]. Such comparative data on the HRQOL of colorectal
cancer patients with different cancer stages were limited to the US
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population, which might not be transferable to Asian or Chinese
populations. Furthermore, no study has investigated the HRQOL
of patients with colorectal polyps. The health preference score of
colorectal polyp patients is contributed to the economic evaluation
that informs health policy making. The cost-effectiveness analysis
is one type of economic evaluation, and assesses the health
outcomes in terms of quality-adjusted life years (QALYs)[6]. The
QALYs is calculated by the sum of the life years weighted by the
health preference scores, anchoring on a scale from zero (death) to
one (full health), of each individual staying at specific health state.
Therefore, the health preference of colorectal polyp patients
enables the calculation of QALYs to compare no screening against
alternative colorectal cancer screening strategies in economics
evaluation.
The aims of this study were: to assess the HRQOL, as measured
by Short-Form 12-Item (SF-12) and 6-dimensions (SF-6D) Health
Survey, of patients with different stages of CRN; and to investigate
which clinical factors were related to the HRQOL of patients with
CRN, after adjustment for the socio-demographic characteristics.
Materials and Methods
Ethics Statement
Ethical approval was obtained from The University of Hong
Kong/ Hospital Authority Hong Kong West Cluster institutional
review board (HKU/HA HKW IRB #UW 09-391).
The study was conducted using HRQOL instruments (generic
and health preference measures) to evaluate the HRQOL of
patients with CRN who attended the colorectal specialist
outpatient clinic at the Queen Mary Hospital in Hong Kong
from October 2009 to July 2010. The inclusion criteria were that
the adults patients had known stage of disease classification based
on the colorectal neoplasm screening surveillance guideline[7] and
the American Joint Committee on Cancer (AJCC) staging
classification system for colorectal cancer[8]: 1) Low-risk polyps
group (patients with #2 adenomas or 3–4 adenomas all of which
were not larger than 1 cm); 2) High-risk polyps group (patients
with$5 adenomas or with$3 adenomas at least one of which was
larger than 1 cm); 3) Stage I; 4) Stage II; 5) Stage III and 6) Stage
IV. Those who were classified as unknown stage of disease or
primary tumour site when it was unspecified in the medical record,
those who was diagnosed with CRN for less than six months, those
who had an expected life expectancy of less than six months, and
those who had low literacy and cognitive impairment were
excluded from this study. A total of 698 patients were assessed for
eligibility and 600 eligible patients gave consent to enroll in the
longitudinal study administering questionnaire at baseline, six
months and twelve months later. The baseline data from the
longitudinal study formed the basis of the current study. Five
hundred and fifty-four (response rate: 79.4%) patients completed
the questionnaire either by face-to-face interviews at the outpatient
clinic or by telephone interviews within one month after the first
contact for this research purpose at the outpatient clinic. Details of
recruitment procedure have been described in authors’ previous
publications[9–14].
Matched samples from an external study were used for
comparison of HRQOL between CRN and the Chinese general
population[15]. Age-sex matched controls of 515 samples were
randomly selected from a larger representative 2533 samples of
Chinese general population, who were administered SF-12v2
health survey in the primary care service utilization study in 2010
by trained interviewers.
HRQOL Measures
This study administered the traditional Chinese version of SF-
12v2 and SF-6D Health Surveys, which have been validated[16–
19] and normed[15] in the general Chinese population in Hong
Kong.
The Chinese (HK) SF-12v2 Health Survey is a 12-item generic
HRQOL measure consisted of eight subscales: Physical function-
ing (PF), Role physical (RP), Bodily pain (BP), General health
(GH), Vitality (VT), Social functioning (SF), Role emotional (RE)
and Mental health (MH); and two composite summary scores:
Physical Component Summary (PCS) and Mental Component
Summary (MCS) scores. All subscales and summary scores were
ranged from 0-100. The higher the SF-12 score, the better the
HRQOL outcome. Such generic measure of HRQOL is used for
measuring HRQOL of the general population including individ-
uals living with any health condition, and subsequently enabling
the head-to-head comparison between patients with CRN and
population norm.
The Chinese (HK) SF-6D Health Survey, a subset of SF-12 [20]
and SF-36 [21] Health Surveys, is a 6-item health preference
measure ranging from 0(dead) to 1(perfect health). The SF-6D
health preference scores are calculated by converting health state
into a single index weighted summation from the SF-6D
preference weight coefficients based on published scoring
algorithm for Hong Kong population [22]. The theoretical range
of SF-6D is from 0.315 (worst possible health state) to 1 (perfect
health) based on Hong Kong scoring algorithm.
Patient Characteristics
Self-reported socio-demography including age, gender, marital
status (Married/Non-married), educational level (No formal
schooling/Primary/Secondary/Tertiary or above), household
monthly income (#HKD$20,000/.HKD$20,000, pegged at an
exchange rate of USD$1=HKD$7.8), occupation status (Work-
ing/Non-working), smoking (Ever had/Never had) and drinking
(Ever had/Never had) were collected by interviewers via telephone
or face-to-face interview. Clinical characteristics including stage of
colorectal neoplasm at diagnosis (Polyp: Low-risk and High-risk;
Colorectal cancer: Stage I, II, III and IV), time since diagnosis
(months), family history of colorectal cancer (Parents or sibling/
No), primary tumour site (Colon/Rectum/Sigmoid), colorectal
cancer relapse, active cancer treatment and stoma (Present/
Absent) were retrieved from the electronic medical records. The
later three clinical characteristics were only applicable to 380
patients diagnosed with colorectal cancer.
Statistical Analysis
Socio-demographic and clinical characteristics were described
overall, and by tumour stage at initial diagnosis. Chi-square or
one-way analysis of variance (ANOVA) tests were used to assess
the differences in categorical and continuous variables, respec-
tively, according to the stage at diagnosis. The complete data set
(n = 515), excluding 38 patients with unknown staging/primary
site (n = 12) or missing values in any socio-demographic and
clinical factors (n = 26), was used for further analysis of HRQOL
by mean comparisons and regression analyses. HRQOL scores
were determined for each stage, and the differences between stages
were tested by one-way ANOVA with Tukey’s post hoc test. The
statistical power calculation was based on detecting a difference of
at least 5 points in the SF-12 scores (as extrapolated from
minimum clinically important difference for the SF-36 subscale
scores[23]) between colorectal polyp and cancer groups, with a
standard deviation of 10 for the Chinese population[16] and 80%
power at type I error of 5%. Estimated sample size of 135 was
HRQOL in Chinese Colorectal Neoplasms
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obtained from each group, in total of 270 samples required in this
study.
Normative values of SF-12v2 subscale and summary scores were
extracted from 515 matched controls of 2533 samples reported in
general population survey in Hong Kong[15]. Mean HRQOL
scores of CRN were tested against the general population norms
using independent t-test.
Health preference and two SF-12v2 summary (PCS and MCS)
scores were used as dependent variables in the regression analyses.
Multivariate linear regression analyses were modeled to determine
the effect of clinical factors on dependent variables, controlling for
the effects of socio-demographic factors. No forward or backward
selection procedure was applied for each regression analysis so all
variables were entered in one step only. Each significant regression
coefficients are presented with standard error, a 95% confidence
interval, level of multicollinearity measured by tolerance and
variance inflation factors (VIF). The multicollinearity occurred if
the tolerance statistic was less than 0.1 or VIF was greater than 10
as a rule of thumb. The R2 and adjusted R2 representing the total
variances of dependent variables explained were reported together
with the corresponding regression analyses. Normality of residuals
was examined to check the model validity by residual plot.
The SPSS Windows 20.0 program (IBM SPSS Inc., Chicago IL,
USA) was used for all statistical analyses. A P-value of ,0.05 was
interpreted as statistically significant in all tests.
Results
Sample Characteristics
Table 1 shows the socio-demographic characteristics of the
study subjects. The majority of patients were male (58%), married
(75.2%), not working (75.6%), low household monthly income
(83.6%), non-smokers (73.1%) and non-drinkers (72.3%). The
clinical characteristics of subjects are listed in Table 2. Ninety-
three (16.8%) and 72 (13.0%) subjects were classified as low-risk
and high-risk polyp group, respectively. Eighty-three (15.0%)
patients were subsequently diagnosed with stage I, 101 (18.3%)
with stage II, 114 (20.6%) with stage III and 82 (14.8%) with stage
IV. Of those patients with colorectal cancer, 36 (6.5%) reported
relapse which was more common in advanced stage than in early
stage of cancer. The mean time since diagnosis was 46.7 months
(SD: 55), ranged from 6 to 377 months, with a shorter time since
diagnosis for Stage IV cancer. Thirty-eight point three percent of
primary tumours were located in the colon, 39.8% were at the
rectum and 21% were at the sigmoid colon. Most patients (86.2%)
Table 1. Socio-Demographic Characteristics of Study Subjects by Colorectal Neoplasm Staging.
Polyp (n=165) Colorectal Cancer AJCC Staging (n =381)
Total
(n = 554) P-value Low Risk (n =93)
High Risk
(n =72)
StageI
(n=84)
StageII
(n = 101)
StageIII
(n = 114)
StageIV
(n=82)
Unknown
(n=8)
Age (Year,mean6SD)* 63.3611.3 ,0.001*{ 59.7610.4 63.3612.4 66.8610.3 66610.7 61.7611 62.6612.1 60.6610.8
Sex (%) 0.015{
Male 58.1% 58.1% 77.8% 47.6% 57.4% 56.1% 56.1% 50.0%
Female 41.9% 41.9% 22.2% 52.4% 42.6% 43.9% 43.9% 50.0%
Education Level (%) 0.379
No formal school 10.5% 6.5% 5.6% 9.5% 15.8% 12.3% 12.2% 0.0%
Primary 35.4% 28.0% 43.1% 40.5% 37.6% 31.6% 31.7% 62.5%
Secondary 41.3% 48.4% 38.9% 40.5% 36.6% 42.1% 41.5% 37.5%
Tertiary 12.8% 17.2% 12.5% 9.5% 9.9% 14.0% 14.6% 0.0%
Marital Status (%) 0.063
Married 75.6% 81.7% 81.7% 61.9% 75.2% 76.3% 76.8% 75.0%
Not married 24.4% 18.3% 18.3% 38.1% 24.8% 23.7% 23.2% 25.0%
Currently Working (%){ ,0.001{
Yes 24.4% 37.6% 27.8% 17.9% 18.8% 29.8% 11.0% 37.5%
No 75.6% 62.4% 72.2% 82.1% 81.2% 70.2% 89.0% 62.5%
Household Monthly Income (%) ,0.001{
#HKD$20,000 83.7% 68.5% 80.9% 89.3% 92.0% 80.4% 91.0% 87.5%
.HKD$20,000 16.3% 31.5% 19.1% 10.7% 8.0% 19.6% 9.0% 12.5%
Smoking (%) 0.042{
Ever had 26.9% 26.9% 36.1% 21.4% 31.7% 16.7% 31.7% 37.5%
Never had 73.1% 73.1% 63.9% 78.6% 68.3% 83.3% 68.3% 62.5%
Drinking (%) 0.101
Ever had 27.4% 31.2% 30.6% 16.7% 27.7% 23.7% 34.1% 50.0%
Never had 72.6% 68.8% 69.4% 83.3% 72.3% 76.3% 65.9% 50.0%
Note: AJCC=American Joint Committee on Cancer
*Significant difference between colorectal neoplasm staging (except unknown stage)by One-Way ANOVA
{Significant difference between colorectal neoplasm staging (except unknown stage)by Chi-square Test
{Significant difference between colorectal neoplasm staging (except unknown stage) by Tukey’s Post-hoc multiple comparisons. StageI, StageII . Low Risk
doi:10.1371/journal.pone.0058341.t001
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did not have stoma at the time of assessment, and most patients
(76.9%) finished treatment such as adjuvant and palliative
chemotherapy and/or radiotherapy.
Comparisons among Stage of Disease and with General
Population
Table 3 and Figure 1 presents the subscale and overall mean
SF-12 subscale scores for CRN patients compared with general
population. CRN patients reported statistically worse scores for the
physical aspects of HRQOL (PF, RP and PCS) compared with
general population. For other aspects of HRQOL, CRN patients
reported statistically better scores for BP, GH, VT, RE, MH and
MCS than general population.
Mean HRQOL scores in relation to stage of disease at diagnosis
are presented in Table 4, Figure 2 and Figure 3. Patients with
metastatic colorectal cancer had the lowest HRQOL, with
significantly lower HRQOL scores than low-risk polyp and early
stages of colorectal cancer. There was an unexpected increase
trend in the MCS and health preference scores from early to late
stages of cancer although the differences were not statistically
significant. Health preference scores of stage II patients were
generally higher than those of patients with late stages of cancer.
Correlates of Generic and Health Preference Measures of
HRQOL
Table 5 demonstrates the socio-demographic and clinical
factors associated with generic and health preference measures
of HRQOL by multiple linear regression models. Stage of disease
at diagnosis was the clinical determinants for HRQOL outcomes
with statistical significance in each indicator level of stage. Clinical
and socio-demographic factors explained 11.9% (8.3%), 10.2%
(6.6%) and 14.8% (11.3%) of the total variation, as determined by
R2 (adjusted R2), in PCS, MCS and health preference scores of
patients with CRN, respectively. The multicollinearity did not
occur in our regression models because the tolerance statistic and
VIF were $0.1 and #10, respectively, for all significant regression
coefficients. Health preference score was poorer in patients with
rectal neoplasm (20.0302, 95% CI: 20.0597 to 20.0008) but
better in longer diagnosis duration (0.0002, 95% CI: 0.0000 to
0.0005). MCS and health preference scores were greater in
patients who were male and older. Rectal neoplasm patients
reported worse PCS scores (2.81, 95% CI: 25.14 to 20.47)
compared to sigmoid neoplasm patients. HRQOL scores did not
differ significantly by the presence of chronic co-morbidities and
family history of colorectal cancer.
Discussion
This is the first study, to our knowledge, to compare the
HRQOL in Chinese patients with CRN with the general
population and to highlight the HRQOL differences among stage
of disease at the time of diagnosis. CRN patients reported similar
physical-related HRQOL and better mental-related HRQOL
compared to matched controls from the Chinese general
population. Among all socio-demographic and clinical factors,
Figure 1. Mean SF-12v2 scores of patients with colorectal neoplasms compared with age-sex matched controls from the Chinese
general population.
doi:10.1371/journal.pone.0058341.g001
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stage of disease at diagnosis was the only significant and influential
factor correlated to generic and health preference scores of
HRQOL outcomes. Compared to sigmoid neoplasms, rectal
neoplasms were associated with poorer outcomes on generic and
health preference although mental-related HRQOL showed a
non-significant decline. The effect of time since diagnosis on
HRQOL was positive but significant for health preference scores
only. Socio-demographic factors such as educational level, marital
status, working status, household income, smoking status and
drinking status were not significant correlates of HRQOL
outcomes.
Many studies collected the HRQOL of a sample of CRC
patients and compared with normative values published in
population-based data. Amongst comparative studies, only one
UK study utilized the SF-12 scores comparisons of general
population norms with colorectal cancer patients after surgery[24].
Those cancer survivors had lower PCS score and higher MCS
score compared to the UK population with an age interval of 65–
74 years. Our study found the signs of difference between groups
were consistent with the UK study, regardless of physical-related
and mental-related HRQOL. However, the present study did not
detect significant differences in physical-related HRQOL between
groups, indicating the CRN patients were not associated with
significant impairment of the physical-related HRQOL in Chinese
population.
HRQOL decreased linearly with more severe stages of
colorectal cancer, providing consistent evidence as reported in
European and Australian studies[25–27]. On the other hand,
based on the data presented in the current study, patients with
stage II colorectal cancer reported better HRQOL than those with
stage I colorectal cancer but worse HRQOL than those with
advanced stage of cancer. These particular findings were in line
with two previous US studies which assessed the health preference
scores using the Health Utility Index Mark III (HUI3) among
colorectal cancer patients with 13–24 months from diagnosis[3];
and assessed the vitality subscale using the SF-36 Health Survey
among long term colorectal cancer survivors who were at least five
years from initial diagnosis[4]. However, no evidence from the US
studies [3,4,28–30] had a tendency of relationship between stage
at diagnosis and HRQOL. One of the possible reasons was, in
turn, the change in the perception (or re-conceptualization) of
HRQOL so called response shift [31], as a result of either clinical
interventions or self-coping with colorectal cancer[32].
The present study suggested that factors associated with
HRQOL scores were different from those related to health
preference scores. Significant improvements in patients’ HRQOL
scores, but surprising not in health preference scores, were found
with longer time since CRN diagnosis. Ramsey et al. [3] addressed
that strong and negative impact on health preference measure was
experienced within the first two years of colorectal cancer
diagnosis but the uniform improvement over two years was found.
There was no significant change detected among different time
periods in patients who were at least 13 months [3] and at least 60
months (or 5 years) [4] from initial diagnosis of colorectal cancer.
However, longer time since diagnosis was associated with better
health preference measure. It is postulated that the inconsistent
findings between previous and current studies were in part due to
the differences in the measurement type of ‘Time from Diagnosis’.
Figure 2. Mean SF-12v2 summary scores by stage of disease.
doi:10.1371/journal.pone.0058341.g002
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Figure 3. Mean SF-6D health preference score by stage of disease.
doi:10.1371/journal.pone.0058341.g003
Table 4. Descriptive Statistics (Mean and SD) of Questionnaire Scores at Baseline by CRN Groups
Colorectal Neoplasm Staging
Measure/Scale
Total
(n = 515)
Low Risk
(n=85)
High Risk
(n =66)
Stage I
(n=80)
Stage II
(n = 99)
Stage III
(n =109)
Stage IV
(n=76)
Multiple
Comparison*
SF-12
PF 78.5629.6 85.0624.8 84.1625.8 77.2630.3 85.1625.2 75.7630.7 63.5634.5 1,2,3,4.6
RP 76.2627.6 85.3621.8 80.9622.0 76.7628.8 82.8623.5 74.1626.4 55.9632.8 1.5; 1,2,3,4,5.6
BP 86.7622.9 88.2620.6 92.8616.3 87.2619.9 90.7620.4 83.5625.5 78.9629.2 2,4.6
GH 52.3625.8 55.4624.6 49.9622.6 53.6627.1 57.9624.6 52.0626.0 43.0627.7 1,4.6
VT 67.2619.7 71.2617.9 69.7618.9 66.6622.5 72.2616.7 65.1618.0 57.9622.1 1,2,4.6
SF 81.5628.6 92.1618.2 84.8626.3 81.3627.4 88.6624.0 78.7629.4 61.5634.7 1.5; 1,2,3,4,5.6
RE 89.3619.4 91.9616.2 91.7614.8 91.6617.8 91.4618.7 88.4619.4 80.3625.7 1,2,3,4.6
MH 79.6615.6 80.4614.0 80.1613.0 81.4616.3 80.8615.3 78.9615.8 75.8618.5
PCS 46.9610.6 49.769.0 49.068.7 46.5610.7 49.968.4 45.8610.9 40.4612.5 1,2,3,4,5.6
MCS 57.268.0 58.366.7 57.467.7 58.167.4 58.067.3 56.967.9 54.3610.2 1,3,4.6
SF-6D
Health Preference 0.82560.14 0.87160.12 0.83260.12 0.83160.14 0.85860.12 0.81760.13 0.73260.15 1,2,3,4,5.6
Note:
FACT-C subscales: PWB=physical well-being; SWB= social well-being; EWB= emotional well-being; FWB= functional well-being; CCS = colorectal cancer subscale;
TOI = trial outcome index;
SF-12 subscales: PF =physical functioning; RP = role physical; BP = bodily pain; GH=general health; VT = vitality; SF = social functioning; RE = role emotional; MH=mental
health; PCS = Physical Composite Summary; MCS=Mental Composite Summary
Higher score represents a higher level of functioning or better quality of life
*Significant difference between six colorectal neoplasm groups by Tukey’s Post-hoc multiple comparisons. 1:Low Risk; 2:High Risk; 3:StageI; 4:StageII; 5:StageIII;
6:StageIV;
doi:10.1371/journal.pone.0058341.t004
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Those studies conducted data analysis by partitioning ‘Time from
Diagnosis’ into several time periods as an ordinal factor.
Physical aspect of HRQOL and health preference scores
reported by rectal neoplasm patients were significantly worse than
those scores reported by patients with other primary tumour
locations. It is possible that the impact of tumour site on HRQOL
was primarily due to the effects of treatment modalities. Rectal
neoplasm may be undertaken by the radiotherapy before or after
surgery but colon neoplasm does not. Most of the patients with
rectal cancer underwent resection with the installation of stoma
[10], leading to the burden of daily activities and living. Having
stoma was significantly associated with lower HRQOL scores in
Western populations (e.g. France [33], US [34,35] and Den-
mark[36]). A Japanese study [37] showed that patients with stoma
had worse health preference scores derived using direct valuation
techniques. No significant HRQOL difference among patients
with stoma was found in our Chinese population, which paralleled
with the most recent study on colorectal cancer survivors[38]. One
interpretation of our findings was that HRQOL of patients with
stoma was improved by the growing medical advances in surgical
resection and follow-up stoma care services, and further reduced
the risk of stoma complications and identified better adaptation
and coping strategy to live with stoma [39].
Limitations
Several shortcomings were noted. First, sampling bias regarding
the use of convenience sampling from a specialist outpatient clinic
of one regional hospital in Hong Kong may limit the generaliz-
ability of results to CRN patients in Chinese and other
populations. A high proportion of unemployed, low household
income, or low educated patients in this sample has raised caution
with interpretation and extrapolation the findings to other
populations with different patient characteristics. Moreover,
possible sampling issue related to non-response bias was addressed
in a previous study because subjects who did not respond in follow-
up assessment had a significant inferior HRQOL at the initial
survey than those who did[40]; healthier patients seemed less likely
to be dropped from the follow-up assessments. In such circum-
stance, non-response bias led by the dropout of consented subjects
with inferior HRQOL may potentially underestimate the
HRQOL in this study. Second, R2 (or adjusted R2) did not exceed
20% in linear regression analyses, suggesting that only a small
proportion of the variance in HRQOL outcomes could be
explained by the independent variables. The inclusion of variables
related to adiposity and healthy lifestyle behaviours such as
consumption of fruit and vegetable, and regular exercise, was an
attempt to increase the understanding of underlying factors
associated with HRQOL. Finally, as a cross-sectional study, our
results can only give clues on casual and effect relationships but not
the definitive relationships between independent variables and
HRQOL.
Conclusion
Stage of disease at initial diagnosis was the most significant
clinical correlate for all HRQOL outcomes in patients with CRN.
Specificity, those CRN patients who simultaneously had rectum as
primary tumor site and severe stage of disease at diagnosis,
indicated suboptimal HRQOL in relation to physical aspect of
HRQOL and health preference scores. Based on available
Chinese data on health preference scores, the QALYs is estimated
for the cost-effectiveness analysis of CRN-related interventions in
economics evaluation.
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